UY31646A1 - USE OF SUBSTITUTED PHENYLIMIDAZOLIDINS TO PRODUCE MEDICINES FOR THE TREATMENT OF METABOLIC SYNDROME - Google Patents

USE OF SUBSTITUTED PHENYLIMIDAZOLIDINS TO PRODUCE MEDICINES FOR THE TREATMENT OF METABOLIC SYNDROME

Info

Publication number
UY31646A1
UY31646A1 UY031646A UY31646A UY31646A1 UY 31646 A1 UY31646 A1 UY 31646A1 UY 031646 A UY031646 A UY 031646A UY 31646 A UY31646 A UY 31646A UY 31646 A1 UY31646 A1 UY 31646A1
Authority
UY
Uruguay
Prior art keywords
treatment
metabolic syndrome
substituted
phenylimidazolidins
produce
Prior art date
Application number
UY031646A
Other languages
Spanish (es)
Inventor
Dr Anita Diu-Hercend
Dr Antony Bigot
Dr Irvin Winkler
Dr Matthias Gossel
Dr Siegfried Stengelin
Dr Gerhard Jaehne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31646A1 publication Critical patent/UY31646A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

El uso de fenilimidazolidinas sustituidas para producir medicamentos para el tratamiento del síndrome metabólico. La invención se refiere al uso de los compuestos de la fórmula I en el que los radicales son cada uno definidos como se especifica para producir un medicamento para el tratamiento del síndrome metabólicoThe use of substituted phenylimidazolidines to produce drugs for the treatment of metabolic syndrome. The invention relates to the use of the compounds of the formula I in which the radicals are each defined as specified to produce a medicament for the treatment of metabolic syndrome.

UY031646A 2008-02-07 2009-02-06 USE OF SUBSTITUTED PHENYLIMIDAZOLIDINS TO PRODUCE MEDICINES FOR THE TREATMENT OF METABOLIC SYNDROME UY31646A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08290132 2008-02-07

Publications (1)

Publication Number Publication Date
UY31646A1 true UY31646A1 (en) 2009-08-31

Family

ID=39502138

Family Applications (1)

Application Number Title Priority Date Filing Date
UY031646A UY31646A1 (en) 2008-02-07 2009-02-06 USE OF SUBSTITUTED PHENYLIMIDAZOLIDINS TO PRODUCE MEDICINES FOR THE TREATMENT OF METABOLIC SYNDROME

Country Status (5)

Country Link
AR (1) AR071345A1 (en)
CL (1) CL2009000257A1 (en)
TW (1) TW200946114A (en)
UY (1) UY31646A1 (en)
WO (1) WO2009097996A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2566853B1 (en) 2010-05-05 2017-01-25 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
EA201791982A1 (en) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. METHODS FOR TREATING A NON-ALCOHOLIC FAT LIVER DISEASE AND / OR LIPODYSTROPHY
KR20190122664A (en) * 2017-01-18 2019-10-30 코히러스 바이오사이언시스, 인크. PPARγ Agonists for the Treatment of Huntington's Disease
EP3606527A1 (en) 2017-04-03 2020-02-12 Coherus Biosciences, Inc. Ppar-gamma agonist for treatment of progressive supranuclear palsy
CN112759550A (en) * 2019-11-04 2021-05-07 上海科技大学 Smooth receptor antagonist
CN113024513A (en) * 2021-03-22 2021-06-25 中国药科大学 Novel androgen receptor degradation agent, preparation method and medical application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (en) * 1992-07-08 1994-09-02 Roussel Uclaf New substituted phenylimidazolidines, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
AR071345A1 (en) 2010-06-16
CL2009000257A1 (en) 2009-06-26
WO2009097996A1 (en) 2009-08-13
TW200946114A (en) 2009-11-16

Similar Documents

Publication Publication Date Title
NI201500077A (en) NOVELTY BENZIMIDAZOLE DERIVATIVES AS EP4 ANTAGONISTS
CU20140048A7 (en) NEW PURINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISORDERS
CO6781507A2 (en) Novel heterocyclic derivatives
UY32094A (en) HETEROCYCLIC DERIVATIVES, PROCESSES FOR THEIR PREPARATION, DRUGS THAT INCLUDE SUCH COMPOUNDS AND THEIR USE.
CR20140161A (en) BENZILINDAZOLS REPLACED FOR USE AS INHIBITORS OF QUINASA BUB1 IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
CR20150326A (en) AUTOTAXIN INHIBITORS
CU20130036A7 (en) TRIAZINA-OXIDAZOLES
CU20120099A7 (en) DERIVATIVES OF PIRAZINA AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
DOP2014000115A (en) USE OF SUBSTITUTED 4-PHENYL-PYRIDINS FOR THE MANUFACTURE OF USEFUL MEDICINES IN THE TREATMENT OF DISEASES RELATED TO THE NK1 RECEIVER
CO6771417A2 (en) Lysophosphatidic acid receptor antagonists and their use in the treatment of fibrosis
CR20140525A (en) N-alkyltriazole compounds as LPAR antagonists
CO6751268A2 (en) Novel cyclic azabenzimidazole derivatives useful as antidiabetic agents
UY33458A (en) HETEROCYCLICALLY SUBSTITUTED METOXYPHENYL DERIVATIVES WITH AN OXO GROUP, PROCEDURES FOR THE PREPARATION AND USE OF THE SAME AS MEDICATIONS
UY31053A1 (en) HETEROCICLICAL DERIVATIVES, PROCESSES FOR THEIR PRODUCTION, DRUGS THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE
UY31645A1 (en) NEW PHENYL-SUBSTITUTED IMIDAZOLIDINS, PROCEDURE FOR PREPARATION, MEDICATIONS THAT INCLUDE SUCH COMPOUNDS AND THEIR USE.
NI201500050A (en) BENZAMIDES
ECSP14013215A (en) NEW COMPOUNDS
UY33817A (en) ? NEW BENCYLIC OXINDOLPIRIMIDINES ?.
CR20130569A (en) EPOXIEICOSATRIENOIC ACID ANALOGS AND METHODS OF TAKING AND USING THE SAME
DOP2014000114A (en) NOVEL 2HINDAZOLES AS EP2 RECEPTOR ANTAGONISTS
CO7350640A2 (en) Dimeric compounds
UY35906A (en) NEWS DERIVED FROM BENCIMIDAZOL AS LIGANDOS OF EP4
UY31646A1 (en) USE OF SUBSTITUTED PHENYLIMIDAZOLIDINS TO PRODUCE MEDICINES FOR THE TREATMENT OF METABOLIC SYNDROME
CO6341625A2 (en) DERIVATIVES OF INDOL AS ANTI-CANCER AGENTS
CR20150148A (en) AZAINDOLINS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130513